Darah Protas

Darah practices general corporate and securities law, with an emphasis on complex securities transactions. She represents top investment banks and companies across the healthcare and life sciences, technology, and consumer and retail sectors on equity and debt offerings, including initial public offerings (IPOs), follow-on offerings, private placements, and high-yield, investment-grade and convertible debt offerings.

Darah also counsels publicly traded companies on general corporate and securities matters, including Securities and Exchange Commission (SEC) reporting, corporate governance issues and stock exchange requirements.

Since 2017, Darah has completed 100+ securities transactions, including 20 IPOs, that raised more than $19 billion for companies.

Darah’s notable representative matters include:

• Apellis Pharmaceuticals’ $150 million IPO and several follow-on and convertible senior notes offerings raising more than $1.2 billion in aggregate*
• Appian’s $141 million follow-on offering
• Apogee Therapeutics’ $345 million IPO and $483 million follow-on offering*
• Argenx’s several follow-on offerings raising more than $2.4 billion in aggregate*
• Dyne Therapeutics’ $268 million IPO and several follow-on offerings raising $887.4 million in aggregate*
• Etsy’s $650 million senior convertible notes offering
• Karuna Therapeutics’ several follow-on offerings raising more than $1.3 billion in aggregate*
• Meredith Corporation’s several senior notes offerings raising $1.7 billion in aggregate
• Olink Holdings’ $406 million IPO and its $267 million secondary offering*
• Rapport Therapeutics’ $174 million IPO
• Silvaco’s $114 million IPO*
• SOPHiA GENETICS’ $243 million IPO*
• Verve Therapeutics’ $307 million IPO and several follow-on offerings raising more than $400 million in aggregate*
• Vital Farms’ $235 million IPO
• Zoetis’ $1.25 billion investment grade bond offering

* Indicates investment bank representation

The Legal 500 US recognizes Darah as a Rising Star for Capital Markets: Equity Offerings.